Stockreport

NovaBridge Reports Full Year 2025 Financial Results and Provides Business Update

NovaBridge Biosciences - American Depositary Shares  (NBP) 
PDF Successful transformation to global biotech platform with two mid-stage potential best-in-class/first-in-class programs, givastomig and VIS-101, with compelling proof-of [Read more]